Medibios Laboratories Limited

Medibios Laboratories Limited - pharma in Mumbai. FY 2026 financials and compliance.
CIN U24230MH1995PLC086180 Incorporated 08 March 1995 ROC Mumbai
Merged Public Limited Company pharma
Data last updated
Revenue · FY 2023
₹100.12 Cr
▼ 2.00% YoY
EBITDA · FY 2023
*****
▼ 1.00% YoY
Net profit · FY 2023
*****
▼ 3.00% YoY
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹7.1 Cr
Issued & subscribed
Open charges
None
Satisfied ₹39.29 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
138
Latest available

About Medibios Laboratories Limited

Data last updated: 30 July 2025

Medibios Laboratories Limited was a public limited company. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It specialised in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 08 March 1995.

Registered with ROC Mumbai under CIN U24230MH1995PLC086180.

Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹7.1 Cr. Formerly known as Medibios Laboratories Private Limited. It was led by directors including Yogesh Rajendra Gole and Tushar Anil Korday.

Last AGM: 30 September 2023. Financial statements filed for year ended 31 March 2023. Office: Mumbai, Maharashtra.

As per the financials filed for FY 2023, the company reported a revenue of ₹100.12 Cr, a decline of 2% compared to the previous year.

The company had a reported workforce of approximately 138 employees prior to being dissolved.

The company was associated with 1 brand - Medibios. As per MCA filings, the company had satisfied charges of ₹39.29 Cr on record.

The company has been merged (amalgamated) with another entity and no longer exists separately. Business activities, if any, continue under the successor entity. The last known website on record is medibios.in.

Company Details of Medibios Laboratories Limited
CIN U24230MH1995PLC086180
Registration Number 086180
Incorporation Date 08 March 1995
ROC Mumbai
Listing Status Unlisted
Company Status Amalgamated
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
Key People
Tushar Anil Korday Managing Director Rajendra Fattesinh Gole Whole-Time Director Yogesh Rajendra Gole Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    **************
  • Website
    medibios.in
  • Social Media
  • Registered Address
    102 Shree Mangalam 1St Floor Kulupwadi, Borivali(E) India, Mumbai, Maharashtra, India
  • Industry
    Pharma, Drug Formulation & Development
Company report
Medibios Laboratories Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Medibios Laboratories Limited report

Financials, compliance, directors, charges, ownership and filings for Medibios Laboratories Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Medibios Laboratories Limited

Medibios Laboratories Limited has one previous CIN (Corporate Identification Number): U24230MH1995PTC086180. The current CIN is U24230MH1995PLC086180, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24230MH1995PLC086180 Current
U24230MH1995PTC086180 Previous

Associated Brands with Medibios Laboratories Limited

Medibios Laboratories Limited operates one associated brand: Medibios. These brands represent Medibios Laboratories Limited's diversified market presence and brand portfolio.

Brand Description Website
Medibios
Manufacturing of pharmaceuticals including cardiovascular and anti-infective drugs in India. medibios.in

Business Activity of Medibios Laboratories Limited

Medibios Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Medibios Laboratories Limited

Medibios Laboratories Limited is audited by ANIL THAKRAR AND CO for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
ANIL THAKRAR AND CO blur-value blur-value blur-value

Board of Directors of Medibios Laboratories Limited

Medibios Laboratories Limited is currently managed by 6 directors, with 9 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Directors (as last reported)
Name Designation Appointment Date Tenure Status
Yogesh Rajendra Gole Director 01 Nov 2011 14 Years 8 Months As last reported
Tushar Anil Korday
Also directs: Emil Pharmaceutical Industries Private Limited, Pharmaceuticals Export Promotion Council Of India, Emil Healthcare Private Limited and 1 more
Managing Director 14 May 2010 16 Years 1 Months As last reported
Sharad Kantilal Sheth
Also directs: Mehta Chokshi & Shah Llp
Director 20 Mar 2018 8 Years 3 Months As last reported
Meena Sanjiv Kapadi
Also directs: Prime Property Development Corporation Limited, Flamingo Pharmaceuticals Limited, B4u Broadband (India) Private Limited and 1 more
Director 20 Mar 2018 8 Years 3 Months As last reported
Rajendra Fattesinh Gole Whole-Time Director 20 Mar 2018 8 Years 3 Months As last reported
View all directors

Financials of Medibios Laboratories Limited FY 2023 filings available

Medibios Laboratories Limited reported revenue of ₹100.12 Cr (down 2% YoY) for FY 2023. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹100.12 Cr ▼ -2%
Profit
***** ▼ -3%
EBITDA
***** ▼ -1%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Medibios Laboratories Limited

As of FY 2023, Medibios Laboratories Limited's shareholding pattern shows 99.70% by promoters, 0.30% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings of Medibios Laboratories Limited

Open charges
₹0
Satisfied charges
₹39.29 Cr
Breakdown by lending institutions
State Bank of India₹22.29 Cr
Axis Bank Limited₹17.00 Cr
Latest charge details
DateLenderAmountStatus
26 Jun 2018 Axis Bank Limited ₹17 Cr Satisfied
09 Nov 2000 State Bank of India ₹2.34 Cr Satisfied
17 May 1999 State Bank of India ₹19.95 Cr Satisfied

Total charge records: 3 View all charges

Employees and EPFO Compliance at Medibios Laboratories Limited

Medibios Laboratories Limited has a workforce of 138 employees as of Apr 05, 2024.

Employee count
138
Active EPFO establishments
1
Employee growth
3.76%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Medibios Laboratories Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Medibios Laboratories Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Medibios Laboratories Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Medibios Laboratories Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Medibios Laboratories Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Medibios Laboratories Limited

MSME Payment Delays by Medibios Laboratories Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Medibios Laboratories Limited

Subsidiaries & Group Companies of Medibios Laboratories Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Medibios Laboratories Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Medibios Laboratories Limited

MCA Filings & Documents of Medibios Laboratories Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Medibios Laboratories Limited

Activity
30 Sep 2023
Medibios Laboratories Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Activity
31 Mar 2023
Medibios Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Charges
04 Jun 2021
A charge registered on 26 Jun 2018 via Charge ID 100190200 with Axis Bank Limited was fully satisfied on 04 Jun 2021.
Charges
26 Jun 2018
A charge with Axis Bank Limited amounted to Rs. 17.00 Cr with Charge ID 100190200 was registered on 26 Jun 2018.
Directors
20 Mar 2018
Sangeeta Amitkumar Dhanuka was appointed as a Company Secretary on 20 Mar 2018 & has been associated with this company since 8 years 3 months.
Directors
20 Mar 2018
Sharad Kantilal Sheth was appointed as a Director on 20 Mar 2018 & has been associated with this company since 8 years 3 months.

Frequently Asked Questions about Medibios Laboratories Limited

Medibios Laboratories Limited has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

Medibios Laboratories Limited is a amalgamated public limited company in the pharma sector. It was incorporated on 08 March 1995 and is registered under CIN U24230MH1995PLC086180. The company was amalgamated as per MCA records and no longer exists as a legal entity.

Medibios Laboratories Limited was incorporated on 08 March 1995. Registered with ROC Mumbai.

The current directors of Medibios Laboratories Limited are:

The CIN (Corporate Identification Number) of Medibios Laboratories Limited is U24230MH1995PLC086180. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The primary industry of Medibios Laboratories Limited is pharma. The company specifically operates in drug formulation and development.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available